Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals, Honorary Professor at University of Sheffield and Visiting Professor at Sheffield Hallam University. He is particularly interested in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms, and provides a tertiary service in lower urinary tract reconstructive surgery. He trained at the Middlesex Hospital where he completed his doctorate thesis. He continued there and the Institute of Urology in London for his sub-specialist training. He is Secretary General of the European Association of Urology, having previously been Chairman of the International Relations Committee, Adjunct Secretary General Responsible for Education, and Director of the European School of Urology. He is the Coordinator of the European Reference Network (ERN) for rare urogenital diseases and complex conditions (eUROGEN); a network of 29 healthcare providers across Europe. He was editor-in-chief of the journal Neurourology and Urodynamics from 2006-2016 and is on the editorial board of several international journals. He is an active member of many urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He has chaired a number of guidelines initiatives including the NICE GDG on Male LUTS and the ICUD Consultation on Male LUTS. BAUS awarded him the St Peter’s medal 2011 and SUFU awarded him the Lifetime Achievement Award in 2015. Prof. Chapple has co-authored 750+ articles, comments and letters in peer-reviewed journals, and has written several chapters and books.William D. Steers, deceased, is co-editor of the first edition of this book and, former Chair of Urology at the University of Virginia. This book is dedicated to Dr. Steers’ many accomplishments and outstanding personal attributes. Christopher P. Evans, MD, FACS. Dr. Evans is currently Professor and Chairman, Department of Urology at the University of California, Davis, School of Medicine in Sacramento, California. Dr. Evans joined U.C. Davis in 1997 following urology training at University of California, San Francisco and surgical urologic oncology training at the University of Texas, M.D. Anderson Cancer Center. He is a member of the UC Davis Comprehensive Cancer Center and his practice is dedicated to all aspects of urologic oncology. Dr. Evans’ research focuses on oncogenic activation of the androgen receptor and mechanisms regulating castration-resistant prostate cancer therapeutic resistance. He is an elected member of the American Association of Genitourinary Surgeons, President of the Society of Urologic Oncology and past Steering Committee Chair of ASCO GU.
